Nanoparticle Albumin-Bound-Paclitaxel: A Limited Improvement Under the Current Therapeutic Paradigm of Pancreatic Cancer

Expert Opinion on Pharmacotherapy - United Kingdom
doi 10.1517/14656566.2015.1016912
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa Healthcare

Related search

Targeted Delivery for Breast Cancer Therapy: The History of Nanoparticle-Albumin-Bound Paclitaxel

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2010English

Repetitive Responses to Nanoparticle Albumin-Bound Paclitaxel and Carboplatin in Malignant Pleural Mesothelioma

Respirology Case Reports
PulmonaryRespiratory Medicine
2016English

Targeted Delivery of Albumin Bound Paclitaxel in the Treatment of Advanced Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2009English

Weekly Intravenous Nanoparticle Albumin-Bound Paclitaxel for Elderly Patients With Stage IV Non-Small-Cell Lung Cancer: A Series of 20 Cases

Journal of Biomedical Research
BiochemistryMedicineGeneticsMolecular Biology
2012English

A Feasibility Study of Bevacizumab Plus Dose-Dense Doxorubicin-Cyclophosphamide (AC) Followed by Nanoparticle Albumin-Bound Paclitaxel in Early-Stage Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2011English

Phase I Trial of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Thoracic Malignancies

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2008English

Higher Rate of Skin Rash in a Phase II Trial With Weekly Nanoparticle Albumin-Bound Paclitaxel and Cisplatin Combination in Chinese Breast Cancer Patients

BMC Cancer
Cancer ResearchOncologyGenetics
2013English

SPARC Is a Possible Predictive Marker for Albumin-Bound Paclitaxel in Non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Targeting Anticancer Drug Delivery to Pancreatic Cancer Cells Using a Fucose-Bound Nanoparticle Approach

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy